Back to Search
Start Over
Personalized laboratory medicine: a patient-centered future approach
- Source :
- Prodan Žitnik, I, Černe, D, Mancini, I, Simi, L, Pazzagli, M, Di Resta, C, Podgornik, H, Repič Lampret, B, Trebušak Podkrajšek, K, Sipeky, C, Van Schaik, R, Brandslund, I, Vermeersch, P, Schwab, M & Marc, J 2018, ' Personalized laboratory medicine : A patient-centered future approach ', Clinical Chemistry and Laboratory Medicine, vol. 56, no. 12, pp. 1981–1991 . https://doi.org/10.1515/cclm-2018-0181, Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Chemistry and Laboratory Medicine, 56(12), 1981-1991. De Gruyter
-
Abstract
- In contrast to population-based medical decision making, which emphasizes the use of evidence-based treatment strategies for groups of patients, personalized medicine is based on optimizing treatment at the level of the individual patient. The creation of molecular profiles of individual patients was made possible by the advent of "omics" technologies, based on high throughput instrumental techniques in combination with biostatistics tools and artificial intelligence. The goal of personalized laboratory medicine is to use advanced technologies in the process of preventive, curative or palliative patient management. Personalized medicine does not rely on changes in concentration of a single molecular marker to make a therapeutic decision, but rather on changes of a profile of markers characterizing an individual patient's status, taking into account not only the expected response to treatment of the disease but also the expected response of the patient. Such medical approach promises a more effective diagnostics with more effective and safer treatment, as well as faster recovery and restoration of health and improved cost effectiveness. The laboratory medicine profession is aware of its key role in personalized medicine, but to empower the laboratories, at least an enhancement in cooperation between disciplines within laboratory medicine will be necessary. ispartof: CLINICAL CHEMISTRY AND LABORATORY MEDICINE vol:56 issue:12 pages:1981-1991 ispartof: location:Germany status: published
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Cost effectiveness
Process (engineering)
molecular profiling
proteome
Clinical Biochemistry
Population
Medical laboratory
MINIMAL RESIDUAL DISEASE
Disease
ACUTE MYELOID-LEUKEMIA
03 medical and health sciences
advanced omics technologie
PRECISION MEDICINE
SAFER
Patient-Centered Care
medicine
Medical Laboratory Science
Humans
OMIC TECHNOLOGIES
Medical physics
Precision Medicine
education
genome
advanced omics technologies
education.field_of_study
Science & Technology
HYPERTROPHIC CARDIOMYOPATHY
business.industry
diagnostic marker
Biochemistry (medical)
ADVERSE DRUG-REACTIONS
General Medicine
MASS-SPECTROMETRY
BIOMARKER DISCOVERY
3. Good health
THIOPURINE METHYLTRANSFERASE GENOTYPE
Medical Laboratory Technology
030104 developmental biology
IMPLEMENTATION CONSORTIUM GUIDELINES
metabolome
Personalized medicine
Biostatistics
business
Life Sciences & Biomedicine
transcriptome
Subjects
Details
- Language :
- English
- ISSN :
- 14374331 and 14346621
- Volume :
- 56
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Accession number :
- edsair.doi.dedup.....3bdae67c3df2d53c75a233945c14b782
- Full Text :
- https://doi.org/10.1515/cclm-2018-0181